News

Consultation on 2023 EU4Health programme's priorities, strategic orientations and needs

Published on | 3 years ago

Programmes
Health

The Commission launched a targeted consultation on the 2023 EU4Health programme. Deadline: 27 June 2022
The aim is to gather stakeholders’ opinions about current and future EU health priorities, strategic orientations and key health needs to be addressed through EU4Health annual work programmes, as well as providing inputs for reflection on the 2023 EU4Health Work Programme and beyond.

Within the Work Programme, the actions are structured as follows:

  • Strand of action 01: Crisis preparedness
  • Strand of action 02: Health promotion & Disease prevention
  • Strand of action 03: Health systems & healthcare workforce
  • Strand of action 04: Digital Health
  • Strand of action (transversal) 05: Cancer


The link to the Survey can be found here

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1798 articles available search in articles 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.